Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Fradera

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 17, 2019
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflowXavier Fradera, Joey L Methot, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2020
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]Xavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2021
Discovery of a new series of PI3K-δ inhibitors from Virtual ScreeningXavier Fradera, Qiaolin Deng, Abdelganhi Achab, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitorsHua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
The Discovery of Bridged Benzoazepine Amides as Selective Allosteric Modulators of RIPK1Joanna L Chen, Joey L Methot, Matthew J Mitcheltree, et al.
ACS Medicinal Chemistry Letters|September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 InhibitorsBrett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|August 17, 2019
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflowXavier Fradera, Joey L Methot, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2020
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]Xavier Fradera, Joey L Methot, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2021
Discovery of a new series of PI3K-δ inhibitors from Virtual ScreeningXavier Fradera, Qiaolin Deng, Abdelganhi Achab, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitorsHua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
The Discovery of Bridged Benzoazepine Amides as Selective Allosteric Modulators of RIPK1Joanna L Chen, Joey L Methot, Matthew J Mitcheltree, et al.
ACS Medicinal Chemistry Letters|September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 InhibitorsBrett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Pageof 5